Pushing the boundaries of regenerative medicine

Plasticell is leveraging its innovative combinatorial screening technology for a broad range of cell and gene therapy applications, whereas spin-out Progenitor Therapeutics focuses on small-molecule regenerative drug discovery.

Like Comment
Page of
Go to the profile of Plasticell


Plasticell is a biotechnology company that is developing therapies derived from research using its award-winning proprietary high throughput combinatorial cell culture technology named CombiCult®.

No comments yet.